| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| O798068 | MACKLIN | 盐酸奥昔布宁 | 10mM in DMSO | 136元/1ml; | 展开 |
|
| O859252 | MACKLIN | 盐酸奥昔布宁 | ≥99% | 136元/1g; 620元/5g; | 展开 |
|
| O0451 | TCI | Oxybutynin Hydrochloride | >98.0%(HPLC) | 990元/1G; 4150元/5G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(HPLC) | | 分子式/分子量 | C22H31NO3・HCl = 393.95 | | 外观与形状(20℃) | 固体 | | 储存在惰性气体下 | 存放于惰性气体之中 | | 应避免的情况 | 光,湿气 (吸湿) | | Reaxys-RN | 4833152 | | MDL编号 | MFCD00072150 |
技术规格 | Appearance | White to Orange to Green powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 96.0 % | | Specific rotation [a]20/D | -0.1 to +0.1 deg(C=10, water) |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H302 : 吞咽有害。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P301 + P312 + P330 : 如误吞咽:如感觉不适,呼叫急救中心/医生。漱口。
|
相关法规 |
| 200423 | J&K | Oxybutynin Hydrochloride | 99% | 819元/500MG; 1214元/1G; 4176元/5G; | 展开 |
基本信息 | 分子式 | C22H31NO3·HCl | | 分子量 | 393.95 | | MDL编码 | MFCD00072150 | | EINECS 编号 | 216-139-7 |
安全信息 | 图形或危害标志 |  | | 提示语 | Warning | | 危险说明 | H302 | | 防范说明 | P264 P270 P301+P312 P330 P501 | | WGK | 3 | | RTECS | GV2800000 |
|
| C46350 | Alfa Aesar | Oxybutynin Hydrochloride | | 3246元/1g; 11137元/5g; 43740元/25g; | 展开 |
基本信息 Ref# 46350 分子式 C22H31NO3.HCl 分子量 1277.13 GHS危害和防范说明 GHS符号
 Hazard Statements H302 Harmful if swallowed. Precautionary Statements P301+P330+P331 P312 P264 |
| O0288000 | | Oxybutynin Hydrochloride | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C22H31NO3 · HCl | | 分子量 | 393.95 | | MDL编号 | MFCD00072150 | | PubChem化学物质编号 | 329818836 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2 | | InChI | 1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H | | InChI key | SWIJYDAEGSIQPZ-UHFFFAOYSA-N | | Gene Information | human ... CHRM2(1129), CHRM3(1131) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| O2881 | Sigma-Aldrich | Oxybutynin chloride | ≥98% (TLC), powder | 904.42元/500 MG; 1341.59元/1 G; 4614.63元/5 G; | 展开 |
产品说明 包装 1, 5 g in glass bottle 500 mg in glass bottle 生化/生理作用 毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。 特点和优势 This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. 基本信息 | 经验(实验)分子式 | C22H31NO3 · HCl | | 分子量 | 393.95 | | EC 号 | 216-139-7 | | MDL编号 | MFCD00072150 | | PubChem化学物质编号 | 57654480 | | NACRES | NA.77 |
产品性质 | 质量水平 | 200 | | 测定 | ≥98% (TLC) | | 形式 | powder | | 颜色 | white | | 溶解性 | H2O: 50 mg/mL | | 创始人 | Johnson & Johnson | | SMILES string | Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2 | | InChI | 1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H | | InChI key | SWIJYDAEGSIQPZ-UHFFFAOYSA-N | | Gene Information | human ... CHRM1(1128), CHRM2(1129), CHRM3(1131), CHRM4(1132), CHRM5(1133) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
|
| O5015 | Sigma-Aldrich | Oxybutynin chloride | meets EP, USP testing specifications | 1785.42元/1 G; 5408.06元/5 G; | 展开 |
产品说明 包装 1, 5 g in glass bottle 500 mg in glass bottle 生化/生理作用 毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。 基本信息 | 经验(实验)分子式 | C22H31NO3 · HCl | | 分子量 | 393.95 | | EC 号 | 216-139-7 | | MDL编号 | MFCD00072150 | | PubChem化学物质编号 | 24898008 | | NACRES | NA.21 |
产品性质 | 质量水平 | 200 | | agency | USP/NF meets EP testing specifications meets USP testing specifications | | application(s) | pharmaceutical (small molecule) | | 储存温度 | room temp | | SMILES string | Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2 | | InChI | 1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H | | InChI key | SWIJYDAEGSIQPZ-UHFFFAOYSA-N | | Gene Information | human ... CHRM2(1129), CHRM3(1131) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
|
| PHR2547 | Supelco | Oxybutynin chloride | certified reference material, pharmaceutical secondary standard | 1966.23元/500 MG; | 展开 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. 生化/生理作用 毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 基本信息 | 经验(实验)分子式 | C22H31NO3 · HCl | | 分子量 | 393.95 | | MDL编号 | MFCD00072150 |
产品性质 | 等级 | certified reference material pharmaceutical secondary standard | | 描述 | Pharmaceutical Secondary Standard; Certified Reference Material | | 形式 | solid | | CofA | current certificate can be downloaded | | 包装 | pkg of 500 mg | | 药典可追溯性 | traceable to PhEur O0288000 traceable to USP 1485103 | | 储存温度 | 2-30℃ | | SMILES string | Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2 | | InChI | 1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H | | InChI key | SWIJYDAEGSIQPZ-UHFFFAOYSA-N |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1485103 | USP | Oxybutynin chloride | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C22H31NO3 · HCl | | 分子量 | 393.95 | | MDL编号 | MFCD00072150 | | PubChem化学物质编号 | 329750639 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2 | | InChI | 1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H | | InChI key | SWIJYDAEGSIQPZ-UHFFFAOYSA-N | | Gene Information | human ... CHRM2(1129), CHRM3(1131) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P301 + P312 + P330 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP701 | | Oxybutynin Hydrochloride | British Pharmacopoeia (BP) Reference Standard | 1952.55元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C22H31NO3 · HCl | | 分子量 | 393.95 | | EC 号 | 204-717-1 | | MDL编号 | MFCD00072150 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | SMILES string | Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2 | | InChI | 1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H | | InChI key | SWIJYDAEGSIQPZ-UHFFFAOYSA-N | | Gene Information | human ... CHRM2(1129), CHRM3(1131) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P301 + P312 + P330 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0002275 | | Oxybutynin hydrochloride for system suitability | CRS, European Pharmacopoeia (EP) Reference Standard | 1341.2元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pha 生化/生理作用 毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。 包装 Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C22H31NO3 · HCl | | 分子量 | 393.95 | | MDL编号 | MFCD00072150 |
产品性质 | manufacturer/tradename | EDQM | | 储存温度 | 2-8℃ | | SMILES string | Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2 | | InChI | 1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H | | InChI key | SWIJYDAEGSIQPZ-UHFFFAOYSA-N |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|